BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7607382)

  • 1. [Immunohistochemical detection of epidermal growth factor receptor (EGF-R) in paraffin sections of breast carcinoma tissue: correlation and clinical significance].
    Beckmann MW; Tutschek B; Göhring UJ; Engels K; Picard FK; Scharl A; Niederacher D; Schnürch HG
    Geburtshilfe Frauenheilkd; 1995 May; 55(5):258-65. PubMed ID: 7607382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of epidermal growth factor receptor lacks prognostic significance for breast carcinoma.
    Göhring UJ; Ahr A; Scharl A; Weisner V; Neuhaus W; Crombach G; Holt JA
    J Soc Gynecol Investig; 1995; 2(4):653-9. PubMed ID: 9420872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of immunohistochemical determination of receptors, tissue proteases, tumor suppressor proteins and proliferation markers as prognostic indicators in primary breast carcinoma].
    Göhring UJ; Scharl A; Ahr A
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):177-83. PubMed ID: 8682282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidermal growth factor receptor in human breast cancer: correlation with steroid receptors, tumor stage, grading and menopausal status].
    Speiser P; Sliutz G; Zeillinger R; Czerwenka K; Jakesz R; Knogler W; Kury F; Reiner A; Sevelda P; Schneeberger C
    Geburtshilfe Frauenheilkd; 1992 Jun; 52(6):355-9. PubMed ID: 1634099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [C-erbB-2, EGF receptor, p53 and PCNA. The prognostic significance of recent tumor markers for lymph node negative breast cancer].
    Schönborn I; Minguillon C; Lichtenegger W; Zschiesche W; Spitzer E
    Geburtshilfe Frauenheilkd; 1995 Oct; 55(10):566-71. PubMed ID: 8543129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and immunohistochemical detection of the epidermal growth-factor receptor (EGF-R) in breast-tumor specimens.
    Beckmann M; Tutschek B; Kruger K; Niederacher D; Risse B; Ruppert C; Schnurch H; Bender H
    Int J Oncol; 1993 Aug; 3(2):389-97. PubMed ID: 21573379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of the p185neu oncoprotein indicates an unfavorable prognosis in small, node negative breast cancer without systemic adjuvant treatment (T1N0)].
    Göhring UJ; Aslan-Schadwinkel Y; Scharl A
    Geburtshilfe Frauenheilkd; 1993 Sep; 53(9):625-9. PubMed ID: 7901111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study.
    Klijn JG; Look MP; Portengen H; Alexieva-Figusch J; van Putten WL; Foekens JA
    Breast Cancer Res Treat; 1994 Jan; 29(1):73-83. PubMed ID: 8018964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone receptor determination in breast carcinoma tissue. Comparison of recent immunohistologic techniques with biochemical receptor testing].
    Wilkens C; Beck T; Weikel W; Brumm C; Pollow K
    Pathologe; 1995 Jul; 16(4):256-61. PubMed ID: 7667207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistochemical detection of EGF-receptors in breast cancers].
    Kopp A; von Laffert C; Jonat W
    Geburtshilfe Frauenheilkd; 1993 Jul; 53(7):461-6. PubMed ID: 8370486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical detection and prognostic significance of p53 in the primary tumor of breast carcinoma patients].
    Beck T; Weller E; Weikel W; Brumm C; Wilkens C; Knapstein PG
    Geburtshilfe Frauenheilkd; 1995 May; 55(5):252-7. PubMed ID: 7607381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF, TGF-alpha) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status.
    Umekita Y; Enokizono N; Sagara Y; Kuriwaki K; Takasaki T; Yoshida A; Yoshida H
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):345-51. PubMed ID: 1348890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid receptors and prognosis in operable (stage I and II) breast cancer.
    Stewart JF; Rubens RD; Millis RR; King RJ; Hayward JL
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1381-7. PubMed ID: 6315442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of cathepsin D, proliferating cell nuclear antigen and epidermal growth factor receptor in human breast carcinoma analysed by computer image analyser: correlation with histological grade and metastatic behaviour.
    Okamura K; Kobayashi I; Matsuo K; Kiyoshima T; Yamamoto K; Miyoshi A; Sakai H
    Histopathology; 1997 Dec; 31(6):540-8. PubMed ID: 9447385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease.
    Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Branković-Magić M; Kanjer K; Gavrilović D; Mitrović L; Borojević N; Vukotić D; Spuzić I
    J Exp Clin Cancer Res; 1999 Sep; 18(3):347-55. PubMed ID: 10606181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between epidermal growth factor receptor (EGF-R) and other predictors of prognosis in breast carcinomas. An immunohistochemical study.
    Martinazzi M; Crivelli F; Zampatti C; Martinazzi S
    Pathologica; 1993; 85(1100):637-44. PubMed ID: 8170712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study.
    van der Burg ME; Henzen-Logmans SC; Foekens JA; Berns EM; Rodenburg CJ; van Putten WL; Klijn JG
    Eur J Cancer; 1993; 29A(14):1951-7. PubMed ID: 8280488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidermal growth factor receptor (EGF-R) in human breast cancer--a marker of morphologic-functional differentiation].
    Scharl A; Göhring UJ; Vierbuchen M; Küsters B; Würz H
    Geburtshilfe Frauenheilkd; 1990 Nov; 50(11):877-82. PubMed ID: 2283014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor-immunohistochemical detection and clinical significance for treatment of primary breast cancer.
    Schroeder W; Biesterfeld S; Zillessen S; Rath W
    Anticancer Res; 1997; 17(4A):2799-802. PubMed ID: 9252718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.